Can We Stop Reflexively Discontinuing Mineralocorticoid Antagonists for Patients With Heart Failure and Hyperkalemia?

J Card Fail. 2022 Sep;28(9):1464-1468. doi: 10.1016/j.cardfail.2022.05.014. Epub 2022 Jun 9.

¹ Department of Cardiovascular Medicine, University of Kansas School of Medicine, Kansas City, Kansas.
² Department of Medicine, Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Ontario, Canada; The Population Health Research Institute and Research Institute of St. Joseph's, Hamilton, Ontario, Canada.
³ Department of Cardiovascular Medicine, University of Kansas School of Medicine, Kansas City, Kansas. Electronic address: andrewjamessauer@gmail.com.

No abstract available

Keywords: Mineralocorticoid receptor antagonists; SGLT2 inhibitors; heart failure; potassium binders.

Publication types